Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

U.S. House Kicks Off Legislative Phase of ‘21st Century Cures’ Initiative

Washington, DC, April 24, 2015 ― The U.S. House of Representatives Committee on Energy and Commerce yesterday announced that, after nearly a year of listening to patients, innovators, researchers, providers and regulators, 21st Century Cures next week will take the next step in the legislative phase with a hearing.

The hearing — “Legislative Hearing on 21st Century Cures” — will take place on Thursday, April 30 at 10:00 a.m. in room 2123 of the Rayburn House Office Building in Washington, DC.

Subcommittee members will discuss a forthcoming bipartisan discussion draft of this highly anticipated legislation, the product of a yearlong listening session and bipartisan negotiations.

The committee has held eight hearings and issued several white papers in this initiative since its launch last year.

Committee members, both in Washington, D.C., and across the country, have also hosted more than two-dozen roundtables to generate ideas for this initiative.  Staff continues to work together around the clock as they have for the past several months and legislative text will be made available in the coming days.

Scheduled to testify before the House panel are Dr. Kathy Hudson, Deputy Director for Science, Outreach and Policy at the National Institutes of Health; Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research at the Food and Drug Administration; and Dr. Jeff Shuren, Director of the Center for Devices and Radiological Health at the FDA.

The Majority Memorandum, legislative text, and witness testimony will be available online as they are posted.